Kitonail

Ciclopirox, the active ingredient in Kitonail, is an antifungal presented as a topical formulation for topical use. It treats fungal infections of the nails and skin in adults and children as prescribed. GNH USA supplies Kitonail as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ciclopirox is an antifungal that acts on dermatophyte and yeast infections of the skin and nails.

Onychomycosis: reduces fungal growth in infected nails, improving nail appearance. Dermatophytosis: clears fungal infection of the skin, relieving redness and scaling. Tinea pedis: eliminates the causative fungus on the feet, reducing itching and maceration.

Ciclopirox may cause local skin reactions when applied.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or peeling of the skin. - Mild irritation or stinging. - Local swelling.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Contact dermatitis with blistering. - Extensive skin necrosis. - Systemic hypersensitivity reactions. - Persistent ulceration at the site. - Unexplained fever or malaise.

Ciclopirox should be used according to medical guidance and with attention to potential risks. - Application area: apply only to affected skin or nails as directed. - Contraindication: avoid use if known hypersensitivity to ciclopirox or formulation components. - Pregnancy: safety not established; consult a healthcare professional before use. - Breastfeeding: limited data; discuss risks with a physician. - Drug interactions: inform provider of all topical or systemic antifungal agents being used. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ciclopirox may interact with other agents applied to the skin.

Major Interactions (Avoid): - Concurrent use with other topical antifungal medications may increase irritation. - Application over damaged skin with systemic antifungal therapy can enhance systemic absorption.

Moderate Interactions (Monitor Closely): - Use with topical corticosteroids may mask signs of infection. - Co‑administration with systemic antifungals (e.g., itraconazole) may require monitoring for additive effects. - Interaction with adhesive dressings may affect drug delivery. - Use with other metal‑chelating agents may alter efficacy.